TY  - RPRT
TI  - Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer.
AU  - U Halm
AU  - T Schumann
AU  - I Schiefke
AU  - H Witzigmann
AU  - J Mössner
AU  - V Keim
PY  - 2000
DO  - 10.1054/bjoc.1999.1035
UR  - https://pubmed.ncbi.nlm.nih.gov/10737382/
ID  - 10737382
ER  -